Association of New York Heart Association functional class IV symptoms at admission and clinical features with outcomes in patients hospitalized for acute heart failure syndromes

被引:10
|
作者
Asano, Ryotaro [1 ]
Kajimoto, Katsuya [2 ]
Oka, Toshiaki [1 ]
Sugiura, Ryo [1 ]
Okada, Hisayuki [1 ]
Kamishima, Kazuho [1 ]
Hirata, Tetsuo [1 ]
Sato, Naoki [3 ]
机构
[1] Seirei Hamamatsu Gen Hosp, Dept Cardiol, Shizuoka, Japan
[2] Sekikawa Hosp, Div Cardiol, Tokyo, Japan
[3] Musashi Kosugi Hosp, Nippon Med Sch, Internal Med Cardiol & Intens Care Unit, Kawasaki, Kanagawa, Japan
关键词
Acute heart failure syndromes; New York Heart Association functional class; In-hospital outcome; Assessment; PRESERVED SYSTOLIC FUNCTION; EJECTION FRACTION; RISK STRATIFICATION; NATURAL-HISTORY; OPTIMIZE-HF; MORTALITY; MANAGEMENT; REGISTRY; CLASSIFICATION; PREDICTORS;
D O I
10.1016/j.ijcard.2016.12.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It remains unclear whether there are subgroups of acute heart failure syndromes (AHFS) patients in whom New York Heart Association (NYHA) class IV symptoms at admission is related to a higher risk of mortality because of the heterogeneity of this patient population. The aim of this study was to evaluate the association of NYHA class IV symptoms at baseline with in-hospital mortality in subgroups of patients with AHFS. Methods and Results: Of the 4842 patients enrolled in the Acute Decompensated Heart Failure Syndromes (ATTEND) registry, 4786 patients were included in this analysis. The primary endpoint was in-hospital all-cause death. NYHA class IV at baseline was detected in 44.3% of the patients. The all-cause death rate was significantly higher in patients with NYHA class IV than in those with NYHA class II or III (9.0% vs. 4.3%, P < 0.001). To examine the heterogeneity of the association between NYHA class IV symptoms at baseline and in-hospitalmortality, subgroup analyses were performed. As a result, the presence of NYHA class IV symptoms on admission was associated with a significantly higher risk of all-cause death in patients aged >= 75 years, female patients, patients without an idiopathic dilated etiology, and patients with preserved ejection fraction (EF). Conclusions: This study demonstrated that an age >= 75 years, female gender, the absence of idiopathic dilated etiology, and a preserved EF should be considered when assessing the clinical significance of NYHA class IV symptoms in relation to the risk of in-hospital mortality in patients hospitalized for AHFS. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:585 / 591
页数:7
相关论文
共 50 条
  • [1] Association between anemia, clinical features and outcome in patients hospitalized for acute heart failure syndromes
    Kajimoto, Katsuya
    Sato, Naoki
    Takano, Teruo
    [J]. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2015, 4 (06) : 568 - 576
  • [2] Comparing Patient Reported Outcomes and New York Heart Association Class Among Patients Hospitalized for Heart Failure
    Cosiano, Michael F.
    Vista, Andrew
    Sun, Jie-Lena
    Alhanti, Brooke
    Harrington, Josephine
    Butler, Javed
    OConnor, Christopher M.
    Hernandez, Adrian F.
    Starling, Randall
    Mentz, Robert J.
    Greene, Stephen J.
    [J]. CIRCULATION, 2022, 146
  • [3] Effect of Cardiac Resynchronization Therapy in Patients With New York Heart Association Functional Class IV Heart Failure
    van Bommel, Rutger J.
    van Rijnsoever, Eva
    Borleffs, C. Jan Willem
    Delgado, Victoria
    Marsan, Nina Ajmone
    Bertini, Matteo
    Schalij, Martin J.
    Bax, Jeroen J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (08): : 1146 - 1151
  • [4] Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure
    Cosiano, Michael F. F.
    Vista, Andrew
    Sun, Jie-Lena
    Alhanti, Brooke
    Harrington, Josephine
    Butler, Javed
    Starling, Randall C. C.
    Mentz, Robert J. J.
    Greene, Stephen J. J.
    [J]. CIRCULATION-HEART FAILURE, 2023, 16 (01) : E010107
  • [5] CARDIAC RESYNCHRONIZATION THERAPY FOR NEW YORK HEART ASSOCIATION CLASS IV HEART FAILURE PATIENTS
    Okutucu, S.
    Aksoy, H.
    Sabanov, C.
    Maharjan, N.
    Evranos, B.
    Sahiner, L.
    Kaya, E. B.
    Aytemir, K.
    Kabakci, G.
    Tokgozoglu, L.
    Ozkutlu, H.
    Oto, A.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S63 - S63
  • [6] Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure
    Macdonald, PS
    Keogh, AM
    Aboyoun, CL
    Lund, M
    Amor, R
    McCaffrey, DJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (04) : 924 - 931
  • [7] New York Heart Association Functional Class Guide Assists With Providers Assessment of Functional Class in Patients With Heart Failure
    Prasun, Marilyn A.
    Mccoy, Thomas P.
    Rathman, Lisa
    Stamp, Kelly D.
    [J]. CIRCULATION, 2021, 144
  • [8] Comparison of Cardiac Resynchronization Therapy Outcomes in Patients With New York Heart Association Functional Class I/II Versus III/IV Heart Failure
    Bank, Alan J.
    Rischall, Ariel
    Gage, Ryan M.
    Burns, Kevin V.
    Kubo, Spencer H.
    [J]. JOURNAL OF CARDIAC FAILURE, 2012, 18 (05) : 373 - 378
  • [9] Impact of obesity on survival and New York Heart Association Functional Class in patients with systolic heart failure
    Taiyem, A.
    Bdeir, M. B.
    Conboy, T.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S191 - S191
  • [10] Agreement between heart failure patients and providers in assessing New York Heart Association functional class
    Williams, Brent A.
    Doddamani, Sanjay
    Troup, Melissa A.
    Mowery, Alison L.
    Kline, Cynthia M.
    Gerringer, Janine A.
    Faillace, Robert T.
    [J]. HEART & LUNG, 2017, 46 (04): : 293 - 299